| CYHB2402054 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-12-04 | | Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CYHS2300075 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Generic Drug | 2023-01-11 | | Jiangsu Litair Pharmaceutical Co Ltd;Nanjing F&S Pharmatech Co Ltd | | | view |
| JYHB2500280 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2025-05-22 | | Abbvie Ltd;AstraZeneca AB | | | view |
| JXHB2300095 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-06-10 | | AstraZeneca AB | | | view |
| JXHB2200123 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-09-02 | | AstraZeneca AB | | | view |
| JYHB2001608 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-08-28 | | Abbvie Ltd;AstraZeneca AB | Filed | 2020-09-11 | view |
| JXHS2400080 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2024-10-11 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHZ2200256 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | License Renew | 2022-09-22 | | Abbvie Ltd;AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHL2500083 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2025-04-16 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JTH2300048 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Disposable Import Drug Application | 2023-02-16 | | Natco Pharma Ltd;Drreddy′s (Beijing) Pharmaceutical Co Limited | | | view |
| CYHS2201475 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Generic Drug | 2022-09-08 | | Hunan Kelun Pharmaceutical Co Ltd | | | view |
| JYHB2300513 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-09-07 | | AstraZeneca AB | | | view |
| CYHS2101943 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Generic Drug | 2021-10-28 | | Qilu Pharmaceutical (Hainan) Co Ltd | | | view |
| JXHS2100001 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-01-12 | | Abbvie Ltd;AstraZeneca AB | In Review | 2021-01-12 | view |
| JYHB2500279 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2025-05-22 | | Abbvie Ltd;AstraZeneca AB | | | view |
| JXHB2300096 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-06-10 | | AstraZeneca AB | | | view |
| JYHB2200065 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2022-01-30 | | Abbvie Ltd;AstraZeneca AB | | | view |
| JYHB2001072 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2020-07-09 | | Abbvie Ltd;AstraZeneca AB | Certificate Issued | 2020-09-15 | view |
| JXHS1800061 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-11-12 | | AstraZeneca AB;Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-12-04 | view |
| JXHS2400081 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2024-10-11 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
